Myla P. Lai-Goldman, Chief Medical Officer of LabCorp and Jack Ballantyne, Forensic Biochemistry/Genetics Professor at University of Central Florida
join GenVault's Scientific Advisory Team
CARLSBAD, Calif., Aug. 5 /PRNewswire/ -- GenVault Corporation today announces that two leading industry experts, Dr. Myla P. Lai-Goldman and Dr. Jack Ballantyne, have joined its Scientific Advisory Board. Dr. Lai-Goldman is currently the Chief Medical Officer, Executive Vice President, and Member of Executive Committee at Laboratory Corporation of America Holdings (LabCorp). Dr. Ballantyne is an Associate Professor of Chemistry at the University of Central Florida and the Associate Director for Research, NCFS with research specializing in forensic biochemistry and genetics.
"Dr. Lai-Goldman's deep experience in transitioning research-based technologies into clinical medicine will prove invaluable to the GenVault team as we explore new technologies and products that enable the standardization of biosample handling not only for the research community, but also for the millions of samples collected in the clinical setting," said David Wellis, CEO of GenVault. "Dr. Ballantyne's unique experience in the development of genetic tools for forensic scientists will provide an additional key resource for GenVault as we begin to apply and extend our current tools into the forensics market in the future. Together with our current SAB members, GenVault has assembled an exceptional group with broad and diverse interest and expertise in improving the management of biological samples."
"Accurate diagnosis of a patient is absolutely related to the quality of the sample to be tested. Providing tools that enable consistent sample quality regardless of the collection or handling conditions can improve diagnostic success. I'm pleased to be a part of the scientific advisory board for this technology," said Dr. Lai-Goldman.
"Sample preservation is the
|SOURCE GenVault Corporation|
Copyright©2008 PR Newswire.
All rights reserved